Your contact

Christina Enke-Stolle

Co-Lead Venture Creation & MAxL

Dr. Petra Burgstaller

Co-Lead Venture Creation & MAxL

Investors meet BioEntrepreneurs

BioAngels is an exclusive matchmaking concept for private investors such as business angels, wealthy individuals, family offices and conventional venture capital investors interested in life sciences & health technology investments.

Matchmaking

We introduce private investors to selected, innovative start-up projects at an early stage. 

BioEntrepreneurs planning a spin-off or start-up in search of investors can apply with us to present their business idea to our BioAngels. The presenting teams will be prepared by us to submit all relevant information needed for deciding on an investment in the life sciences sector in an appropriate manner.

„On the BioAngels Pitch Day, it is easy to talk to the teams. That would be harder on large investment conferences. I also greatly appreciate the exchange with the other investors.“
Dr. Hubert Birner
TVM Capital

Focus on health care sector

Our circle of investors is interested in participating in the following areas:

  • Innovative drug development
  • New diagnosis procedures
  • Big data & digital health
  • New drug technologies and approaches to regenerative drugs
  • Innovative platform technologies and services
„The preparation by the team of BioM was very good and intensive. The criticizing feedback has helped us tailor our presentation to the demands of investors.“
Dr. Kathrin Ladetzki-Baehs
adivo

More on the topic

12.05.2026
Munich-based Sedivention secures €2.9 million seed funding for ambulatory obesity therapy
MedTech startup Sedivention has closed a €2.9 million seed financing round. The round was led by bmp Ventures with the IBG funds. Additional investors include the strategic investment arm of…
Munich-based Sedivention secures €2.9 million seed funding for ambulatory obesity therapy
11.05.2026
NanoStruct secures €2.6 million in seed funding for fast sensor chip-based food safety
The Würzburg-based deep-tech start-up NanoStruct has closed a €2.6 million seed financing round. The lead investors are HTGF, Bayern Kapital, and the Auxxo Female Catalyst Fund. NanoStruct’s…
NanoStruct secures €2.6 million in seed funding for fast sensor chip-based food safety
30.04.2026
BIO-Japan 2026: Register now for the German Pavaillion!
From 08 – 9 October 2026, BIO-Japan will take place in Yokohama (Japan). For the third largest pharmaceutical market in the world, this partnering conference offers a central networking…
BIO-Japan 2026: Register now for the German Pavaillion!